Adaptive Biotechnologies Corp vs e l f Beauty Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while e l f Beauty Inc trades at $94.65 (market cap $5.62B). The key difference: e l f Beauty Inc is the larger of the two by market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, e l f Beauty Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | ELF | |
|---|---|---|
Market Cap | $4.05B | $5.62B |
Sector | Health | Technology |
52-Week High | $25.45 | $146.67 |
52-Week Low | $12.30 | $49.57 |
Enterprise Value | $4.12B | $6.20B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ELF trades at $98.49, up 6.69% in 24 hours, near its 52-week high. The stock exhibits a bullish technical trend with strong support at $93 and resistance at $101. Recent Q2 2026 earnings beat expectations with EPS of $1.75 versus $0.71 expected, driven by 36% revenue growth and the Rhode acquisition. The company raised fiscal 2027 guidance, reflecting robust demand and international expansion.
Outlook remains positive due to consistent sales growth and strategic initiatives, but risks include high valuation (P/E 97.18) and reliance on acquisitions for growth. The stock offers growth potential but faces margin pressure from increased investments and competitive dynamics in the beauty sector.
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →